Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc
Archives of Virology · 2024
DOI: 10.1007/s00705-024-05968-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2024. Verfasst von Kaori Sano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Shinjuku, Tokyo, 162-8640, Japan. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Hemorrhagic Fevers, Viral, Bunyaviridae Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome (SFTS) is a hemorrhagic fever caused by SFTS virus (SFTSV), which is primarily found in East Asian countries. Despite its high mortality rate and increasing incidence, no vaccines or therapeutics have yet been approved for use against SFTS. Antibody drugs have shown promise in treating lethal infectious diseases that currently have no established treatments. In the case of SFTS, however, only a limited amount of research has been done on SFTSV-neutralizing antibodies targeting the transmembrane proteins Gn and Gc, which play critical roles in viral infection. This study focuses on the production and characterization of antibodies targeting the SFTSV Gc protein. Monoclonal antibodies against Gc were generated through immunization of mice, and their antiviral activity was evaluated. Three out of four anti-Gc antibody clones from this study demonstrated dose-dependent SFTSV neutralization activity, two of which exhibited a synergistic effect on the neutralization activity of the anti-Gn antibody clone Mab4-5. Further studies are necessary to identify key sites on the SFTSV glycoprotein and to develop novel agents as well as antibodies with diverse mechanisms of action against SFTSV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Shinjuku, Tokyo, 162-8640, Japan.
- Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
- Department of Microbiology, Faculty of Medicine, University of Toyama, Toyama, Japan.
- Department of Virology, Toyama Institute of Health, Toyama, Japan.
- Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Shinjuku, Tokyo, 162-8640, Japan. tksuzuki@niid.go.jp.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Sano, K., Kimura, M., Sataka, A., Hasegawa, H., Tani, H., & Suzuki, T. (2024). Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc. Archives of Virology. https://doi.org/10.1007/s00705-024-05968-x
Vancouver
Sano K, Kimura M, Sataka A, Hasegawa H, Tani H, Suzuki T. Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc. Archives of Virology. 2024. doi:10.1007/s00705-024-05968-x
BibTeX
@article{Sano2024,
author = {Sano, Kaori and Kimura, Miyuki and Sataka, Akiko and Hasegawa, Hideki and Tani, Hideki and Suzuki, Tadaki},
title = {Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc},
journal = {Archives of Virology},
year = {2024},
doi = {10.1007/s00705-024-05968-x}
}
EUVIMED